Clinical applications of hybrid PET/MRI in neuroimaging

Clinical Nuclear Medicine

Volumn 38, Issue 1, 2013, Pages

  Garibotto, Valentina ^a   Heinzer, Susanne ^a,b   Vulliemoz, Serge ^a   Guignard, Renaud ^a,c   Wissmeyer, Michael ^a   Seeck, Margitta ^a   Lovblad, Karl Olof ^a   Zaidi, Habib ^a   Ratib, Osman ^a   Vargas, Maria Isabel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b PHILIPS HEALTHCARE   (United States)

^c CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

clinical applications; hybrid imaging; neuroimaging; PET MRI

Indexed keywords

AMINO ACID; FLUORODEOXYGLUCOSE F 18; FLUOROETHYLTYROSINE F 18; RADIOPHARMACEUTICAL AGENT; TYROSINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING EQUIPMENT; EPILEPSY; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; MALE; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GLIOBLASTOMA; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; YOUNG ADULT;

EID: 84871665042     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182638ea6     Document Type: Article

References (26)

1. Ratib O, Beyer T. Whole-body hybrid PET/MRI: ready for clinical use? Eur J Nucl Med Mol Imaging. 2011;38:992-995.
2. Boss A, Stegger L, Bisdas S, et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol. 2011;21:1439-1446.
3. Schlemmer HP, Pichler BJ, Schmand M, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology. 2008;248:1028-1035.
4. Beyer T, Pichler B. A decade of combined imaging: from a PET attached to a CT to a PET inside an MR. Eur J Nucl Med Mol Imaging. 2009;36(suppl 1): S1-S2.
5. Zaidi H, Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys. 2011;38:5667-5689.
6. Herzog H, Langen KJ, Weirich C, et al. High resolution brain PET combined with simultaneous MRI. Nuklearmedizin. 2011;50:74-82.
7. Herzog H, Pietrzyk U, Shah NJ, et al. The current state, challenges and perspectives of MR-PET. Neuroimage. 2010;49:2072-2082.
8. Zaidi H, Ojha N, Morich M, et al. Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol. 2011;56: 3091-3106.
9. Ratib O, Lord M, Becker M, et al. Clinical applications of hybrid PET-MR. Med Nucl. 2012. Epub ahead of print.
10. Wissmeyer M, Heinzer S, Majno P, et al. Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT). Eur J Nucl Med Mol Imaging. 2011;38:1744-1745.
11. Lord M, Ratib O, Vallee JP. (18)F-fluorocholine integrated PET/MRI for the initial staging of prostate cancer. Eur J Nucl Med Mol Imaging. 2011;38:2288.
12. Garibotto V, Vargas MI, LovbladKO, et al.APET-MRI case of corticocerebellar diaschisis after stroke. Clin Nucl Med. 2011;36:821-825.
13. Vargas MI, Garibotto V, Viallon M, et al. Peripheral nerves, tumors and hybrid PET-MRI. Clin Nucl Med. In press.
14. Lassmann M. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging. 2008;35:1748.
15. Slates RB, Farahani K, Shao Y, et al. A study of artefacts in simultaneous PET and MR imaging using a prototype MR compatible PET scanner. Phys Med Biol. 1999;44:2015-2027. (Pubitemid 29387608)
16. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008;14: 459-465. (Pubitemid 351499385)
17. Catana C, Wu Y, Judenhofer MS, et al. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J Nucl Med. 2006;47:1968-1976. (Pubitemid 47544984)
18. 18F]FDG, version. Eur J Nucl Med Mol Imaging. 2009;36:2103-2110.
19. Vander Borght T, Asenbaum S, Bartenstein P, et al. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging. 2006;33:1374-1380. (Pubitemid 44630797)
20. Kleis M, Daldrup-Link H, Matthay K, et al. Diagnostic value of PET/CT for the staging and restaging of pediatric tumors. Eur J Nucl Med Mol Imaging. 2009;36:23-36.
21. Punwani S, Taylor SA, Bainbridge A, et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology. 2010;255:182-190.
22. Dukart J, Mueller K, Horstmann A, et al. Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS ONE. 2011;6:e18111.
23. Kantarci K, Lowe VJ, Boeve BF, et al. Multimodality imaging characteristics of dementia with Lewy bodies. Neurobiol Aging. 2012;33:2091-2105.
24. Salamon N, Kung J, Shaw SJ, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71: 1594-1601.
25. Madan N, Grant PE. New directions in clinical imaging of cortical dysplasias. Epilepsia. 2009;50(suppl 9):9-18.
26. Catana C, van der Kouwe A, Benner T, et al. Toward implementing an MRIbased PET attenuation-correction method for neurologic studies on the MRPET brain prototype. J Nucl Med. 2010;51:1431-1438.